Sudeep Pharma Share Price | Sudeep Pharma Stock Screener
SUDEEPPHRM
Pharmaceuticals
Share Price NSE
₹650.10
▲
1.30 (0.20%)
Share Price BSE
₹650.00
▲
2.45 (0.38%)
As of May 20, 2026, the Sudeep Pharma share price (NSE: SUDEEPPHRM) is ₹650.10 on NSE and ₹650.00 on BSE, up 0.20% from the previous close, with shares trading between ₹645.60 and ₹651.00, and a 52-week range of ₹530.00–₹774.15.
Check SUDEEPPHRM annual price range for the annual price range and momentum.
Use the Sudeep Pharma stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Sudeep Pharma Market Cap
₹7,329.80 Cr.
SUDEEPPHRM P/E Ratio (TTM)
43.08
Sudeep Pharma P/B Ratio
8.92
EPS (TTM)
₹12.79
Dividend Yield
-
Debt to Equity
0.25
SUDEEPPHRM 52 Week High
₹774.15
Sudeep Pharma 52 Week Low
₹530.00
Operating Margin
35.00%
Profit Margin
26.82%
SUDEEPPHRM Revenue (TTM)
₹179.00
EBITDA
₹67.00
Net Income
₹48.00
Total Assets
₹717.00
Total Equity
₹493.00
Sudeep Pharma Share Price Chart
Screen Sudeep Pharma share price with an interactive chart. Analyse SUDEEPPHRM price trends and volatility across different timeframes.
Sudeep Pharma Company Profile - Fundamental Screener
Screen Sudeep Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SUDEEPPHRM shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0QPI01025
Sudeep Pharma Balance Sheet Screener
Screen SUDEEPPHRM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 717 | 514 | 344 | 213 | 131 |
| Current Assets | 424 | 275 | 197 | 100 | 56 |
| Fixed Assets | 189 | 180 | 137 | 68 | 60 |
| Liabilities | |||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 49 | 21 | 34 | 19 | 13 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 493 | 356 | 163 | 114 | 81 |
| Share Capital | 12 | 1 | 1 | 1 | 1 |
| Reserves & Surplus | 481 | 355 | 162 | 113 | 80 |
Sudeep Pharma Income Statement Screener - Profit & Revenue Analysis
Screen Sudeep Pharma income statement and profit fundamentals.
Analyze SUDEEPPHRM quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Sudeep Pharma share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun |
|---|---|---|---|---|---|---|---|
| Revenue | 179 | 173 | 130 | 161 | 118 | 151 | 81 |
| Expenses | 112 | 107 | 81 | 99 | 76 | 85 | 52 |
| EBITDA | 67 | 66 | 49 | 63 | 42 | 65 | 30 |
| Operating Profit % | 35.00% | 34.00% | 35.00% | 37.00% | 34.00% | 43.00% | 35.00% |
| Depreciation | 4 | 4 | 3 | 3 | 3 | 3 | 3 |
| Interest | 1 | 2 | 2 | 2 | 1 | 1 | 2 |
| Profit Before Tax | 62 | 60 | 44 | 58 | 38 | 62 | 26 |
| Tax | 14 | 13 | 13 | 14 | 9 | 13 | 9 |
| Net Profit | 48 | 47 | 31 | 44 | 29 | 49 | 17 |
| EPS | 4.29 | 4.20 | 2.84 | 4.54 | 2.65 | 4.49 | 4.49 |
Sudeep Pharma Cash Flow Screener - Liquidity Fundamentals
Screen SUDEEPPHRM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|
| Operating Activities | 49 | 66 | -3 | 35 | 10 |
| Investing Activities | -79 | -49 | -38 | -40 | -23 |
| Financing Activities | 53 | -13 | 51 | 13 | 12 |
| Net Cash Flow | 23 | 4 | 10 | 8 | 0 |
Sudeep Pharma Shareholding Pattern Screener
See Sudeep Pharma shareholding pattern with promoter, FII, and DII holdings.
Check Sudeep Pharma promoter holding and ownership changes for SUDEEPPHRM on TickJournal.
| Item | 2026-Mar | 2025-Jun | 2025-Nov | 2025-Dec |
|---|---|---|---|---|
| Promoter Holding | 76.15% | 91.07% | 89.36% | 76.15% |
| FII Holding | 1.55% | 0.00% | 0.00% | 1.67% |
| DII Holding | 18.11% | 0.00% | 0.00% | 17.60% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 3.11% | 0.00% | 0.00% | 3.27% |
| Other Holding | 1.07% | 8.93% | 10.64% | 1.31% |
| Shareholder Count | 36,503 | 16 | 26 | 43,599 |
Sudeep Pharma Share Dividend Screener - Share Yield Analysis
Check Sudeep Pharma dividend history with payout and yield data.
View Sudeep Pharma dividend details including ex-dates and amounts for SUDEEPPHRM stock.
Sudeep Pharma Stock Index Membership
See which indices include Sudeep Pharma stock.
Check SUDEEPPHRM index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Sudeep Pharma Market Events Screener - Corporate Actions
Get Sudeep Pharma corporate actions including splits, bonuses, and buybacks.
Check Sudeep Pharma stock events that may affect SUDEEPPHRM share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-21 | 2026-05-21 | Quarterly Result Announcement | NA | 2.16% |
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | 4.11% |
| 2025-12-19 | 2025-12-19 | Quarterly Result Announcement | NA | -3.62% |
Sudeep Pharma Competitors Screener - Peer Comparison
Screen SUDEEPPHRM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 450,643 | 41.18 | 54,729 | 9.71% | 10,980 | 64.89 |
| Divis Laboratories | 179,470 | 72.40 | 9,712 | 18.67% | 2,191 | 64.06 |
| Torrent Pharmaceuticals | 149,109 | 65.64 | 11,539 | 6.99% | 1,911 | 58.52 |
| Cipla | 115,682 | 29.94 | 27,712 | -2.46% | 3,783 | 69.78 |
| Dr Reddys Laboratories | 111,567 | 26.84 | 33,593 | -0.44% | 3,998 | 59.87 |
| Lupin | 104,032 | 19.41 | 27,488 | 19.98% | 5,345 | 46.11 |
| Mankind Pharma | 103,325 | 57.32 | 12,744 | 20.90% | 2,007 | 73.37 |
| Zydus Life Science | 101,801 | 20.25 | 23,511 | 18.55% | 4,615 | 69.47 |
| Aurobindo Pharma | 87,806 | 25.19 | 32,346 | 9.43% | 3,484 | 73.83 |
| Laurus Labs | 71,455 | 80.32 | 6,813 | 21.03% | 884 | 80.26 |
Sudeep Pharma Company Announcements - News Screener
Screen SUDEEPPHRM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-18 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-18 | Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financials For The Fourth Quarter And Year Ended 31St March 2026. | - |
| 2026-04-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-26 | Closure of Trading Window | - |
| 2026-03-17 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-02-09 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-02-09 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-02-07 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-02-07 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-06 | Un-Audited Financial Results As On 31.12.2025 | - |
| 2026-02-06 | Board Meeting Outcome for Outcome Of Board Meeting Held On 06.02.2026 | - |
| 2026-02-05 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-02-02 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-02 | Board Meeting Intimation for Approval Of Unaudited Financial Results As On 31St December 2025 Along With Other Business Items | - |
| 2026-01-22 | Announcement Under Regulation 30 (LODR) - Intimation Of Approval For Purchase Of Rights In Leasehold Land In GIDC By Sudeep Advanced Materials Private Limited A Wholly Owned Subsidiary (WOS) Of The Company. | - |
| 2026-01-16 | General Update | - |
| 2026-01-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-26 | Closure of Trading Window | - |